Solebury’s Life Sciences corporate communications group has helped biotechnology, specialty pharma and medical device companies communicate their scientific, clinical development, and operational progress within the competitive landscape—while addressing critical challenges along the way.
From early clinical data through regulatory approvals and commercial launch, we help our clients powerfully articulate and differentiate their science, pipelines and unique value proposition to investors, media, partners, patients, and the scientific and medical communities. We provide strategic counsel, and the full breadth of corporate communications and PR services, including:
Positioning that differentiates, strategy and tactics for impact at key inflection points.
Core to everything we do—illuminating the significance of mechanism, clinical results, presentations at medical meetings, published data.
We are writers, editors, designers and illustrators—dedicated to creating the content that can help bring a Company’s strengths and vision to life, including roadshow/R&D Day/ corporate slide presentations, press releases, talking points, Q&A, and earnings scripts.
Comprehensive PR services around financings (public and private), IPOs, mergers and acquisitions, collaborations, earnings, and other corporate events.
Long-standing relationships with key life science and business journalists; proactive engagement to build awareness near- and long-term.
Addressing questions about technology, data, or regulatory path before they become PR issues—and responding quickly if they do.